NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Canada approves Pfizer-BioNTech Covid-19 vaccine for age 12 and older

By NS Healthcare Staff Writer 06 May 2021

The approval is based on data from the Phase 3 clinical trial, which enrolled 2,260 adolescents aged 12 to 15 years in the US

Roche gets EC approval for Tecentriq to treat....

The EC approval represents Tecentriq’s fourth indication in metastatic NSCLC and fifth

Pfizer reports 45% increase in Q1 2021 net....

Pfizer said that its first-quarter 2021 operational growth was primarily driven by

Athenex to acquire Kuur Therapeutics for $185m

Kuur’s NKT cell platform technology will help Athenex to expand its cell

Swiss firm Roivant Sciences to go public in....

The transaction will enable Roivant Sciences to become a public entity and

Pharmaceuticals

Aceragen acquires Enzyvant’s investigational therapy to treat Farber disease
04 May 21

AstraZeneca gets FDA approval for Farxiga to treat chronic kidney disease
03 May 21

Canada approves Pfizer-BioNTech Covid-19 vaccine for age 12 and older

Roche gets EC approval for Tecentriq to treat....

Pfizer reports 45% increase in Q1 2021 net....

Athenex to acquire Kuur Therapeutics for $185m

Swiss firm Roivant Sciences to go public in....

Pharmaceuticals

Aceragen acquires Enzyvant’s investigational therapy to treat Farber disease
04 May 21

AstraZeneca gets FDA approval for Farxiga to treat chronic kidney disease
03 May 21

Bristol Myers gets FDA priority review for Opdivo to treat bladder cancer
03 May 21

Patient Care

Lumenis gets FDA nod for OptiLight to manage dry eye disease
30 Apr 21

Roche announces five new uses for two Elecsys biomarkers
29 Apr 21

Lucira’s Covid-19 self-test granted interim order authorisation in Canada
27 Apr 21

Nutraceuticals

FDA warns ten companies for illegally selling dietary supplements
22 Feb 21

Abbott expands Pedialyte product line with four new formulations
15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada
18 Nov 20

NS Healthcare is using cookies

Aceragen acquires Enzyvant’s investigational therapy to treat Farber disease04 May 21

AstraZeneca gets FDA approval for Farxiga to treat chronic kidney disease03 May 21

Bristol Myers gets FDA priority review for Opdivo to treat bladder cancer03 May 21

Lumenis gets FDA nod for OptiLight to manage dry eye disease 30 Apr 21

Roche announces five new uses for two Elecsys biomarkers 29 Apr 21

Lucira’s Covid-19 self-test granted interim order authorisation in Canada 27 Apr 21

FDA warns ten companies for illegally selling dietary supplements22 Feb 21

Abbott expands Pedialyte product line with four new formulations15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada18 Nov 20

OUR TITLES

GSK’s anti-PD-1 drug Jemperli granted EC....26 Apr 21

Ro raises $500m funding to expand....24 Mar 21

Why it’s important for data to....18 Mar 21

Thermo Fisher to invest $600m to....11 Mar 21

AstraZeneca gets US FTC nod for....19 Apr 21

Thermo Fisher to acquire clinical research....16 Apr 21

Sanofi acquires mRNA-based technology firm Tidal....12 Apr 21

Hologic to acquire molecular diagnostics firm....09 Apr 21

Novartis to reserve manufacturing capacity for....16 Apr 21

GSK to help manufacture 60 million....30 Mar 21

Starpharma selects LloydsPharmacy to market its....25 Mar 21

Fujifilm Cellular Dynamics out-licenses iPSC technology....18 Mar 21

Aceragen acquires Enzyvant’s investigational therapy to treat Farber disease
04 May 21

AstraZeneca gets FDA approval for Farxiga to treat chronic kidney disease
03 May 21

Bristol Myers gets FDA priority review for Opdivo to treat bladder cancer
03 May 21

Lumenis gets FDA nod for OptiLight to manage dry eye disease
30 Apr 21

Roche announces five new uses for two Elecsys biomarkers
29 Apr 21

Lucira’s Covid-19 self-test granted interim order authorisation in Canada
27 Apr 21

FDA warns ten companies for illegally selling dietary supplements
22 Feb 21

Abbott expands Pedialyte product line with four new formulations
15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada
18 Nov 20

GSK’s anti-PD-1 drug Jemperli granted EC....
26 Apr 21

Ro raises $500m funding to expand....
24 Mar 21

Why it’s important for data to....
18 Mar 21

Thermo Fisher to invest $600m to....
11 Mar 21

AstraZeneca gets US FTC nod for....
19 Apr 21

Thermo Fisher to acquire clinical research....
16 Apr 21

Sanofi acquires mRNA-based technology firm Tidal....
12 Apr 21

Hologic to acquire molecular diagnostics firm....
09 Apr 21

Novartis to reserve manufacturing capacity for....
16 Apr 21

GSK to help manufacture 60 million....
30 Mar 21

Starpharma selects LloydsPharmacy to market its....
25 Mar 21

Fujifilm Cellular Dynamics out-licenses iPSC technology....
18 Mar 21